首页> 美国卫生研究院文献>Journal of RNAi and Gene Silencing : An International Journal of RNA and Gene Targeting Research >Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles
【2h】

Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles

机译:通过突变和野生型报告基因的RNA干扰评估等位基因特异性基因沉默

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Allele-specific gene silencing by RNA interference (RNAi) is therapeutically useful for specifically suppressing the expression of alleles associated with disease. To realize such allele-specific RNAi (ASPRNAi), the design and assessment of small interfering RNA (siRNA) duplexes conferring ASP-RNAi is vital, but is also difficult. Here, we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer′s disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type allelic sequences in their 3′-untranslated regions. We examined the effects of siRNA duplexes against the mutant alleles in allele-specific gene silencing and off-target silencing against the wild-type allele under heterozygous conditions, which were generated by cotransfecting the reporter alleles and siRNA duplexes into cultured human cells. Consistently, the siRNA duplexes determined to confer ASP-RNAi also inhibited the expression of the bona fide mutant APP and the production of either amyloid β 40- or 42-peptide in Cos-7 cells expressing both the full-length Swedish- and wild-type APP alleles. The present data suggest that the system with reporter alleles may permit the preclinical assessment of siRNA duplexes conferring ASP-RNAi, and thus contribute to the design and selection of the most suitable of such siRNA duplexes.
机译:RNA干扰(RNAi)引起的等位基因特异性基因沉默可用于特异性抑制与疾病相关的等位基因的表达。为了实现这种等位基因特异性RNAi(ASPRNAi),设计和评估赋予ASP-RNAi的小干扰RNA(siRNA)双链体至关重要,但也很困难。在这里,我们使用两个报道等位基因编码Photinus和Renilla荧光素酶基因并携带突变型和野生型等位基因序列,显示了与家族性阿尔茨海默氏病有关的瑞典和伦敦型淀粉样前体蛋白(APP)变体的ASP-RNAi他们的3'非翻译区。我们检查了杂合条件下等位基因特异性基因沉默中针对突变等位基因的siRNA双链体的影响和杂合条件下针对野生型等位基因的脱靶沉默的影响,这是通过将报告等位基因和siRNA双链体共转染到培养的人细胞中而产生的。一致地,确定赋予ASP-RNAi的siRNA双链体也抑制了真正的突变体APP的表达以及表达全长瑞典文和野生型的Cos-7细胞中淀粉样β40或42肽的产生。输入APP等位基因。当前数据表明,具有报道基因等位基因的系统可允许对临床上评估赋予ASP-RNAi的siRNA双链体进行评估,从而有助于设计和选择最合适的此类siRNA双链体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号